Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $13.25 Million |
|---|---|
| Enterprise Value | $13.09 Million |
| Earnings per Share | $-0.1 |
| Beta | 1.35 |
| Outstanding Shares | 75,788,153 |
| P/E Ratio | -2.63 |
|---|---|
| PEG | -10.4 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.04 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.49 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerst...